AU5637499A - Chemical compounds iii - Google Patents
Chemical compounds iiiInfo
- Publication number
- AU5637499A AU5637499A AU56374/99A AU5637499A AU5637499A AU 5637499 A AU5637499 A AU 5637499A AU 56374/99 A AU56374/99 A AU 56374/99A AU 5637499 A AU5637499 A AU 5637499A AU 5637499 A AU5637499 A AU 5637499A
- Authority
- AU
- Australia
- Prior art keywords
- chemical compounds
- compounds iii
- iii
- chemical
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9819020.0A GB9819020D0 (en) | 1998-09-01 | 1998-09-01 | Chemical compounds III |
| GB9819020 | 1998-09-01 | ||
| PCT/GB1999/002883 WO2000012482A2 (en) | 1998-09-01 | 1999-09-01 | Indazole derivatives with 5-ht2 receptor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5637499A true AU5637499A (en) | 2000-03-21 |
Family
ID=10838155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56374/99A Abandoned AU5637499A (en) | 1998-09-01 | 1999-09-01 | Chemical compounds iii |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5637499A (en) |
| GB (1) | GB9819020D0 (en) |
| WO (1) | WO2000012482A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| KR20030095183A (en) * | 2000-03-17 | 2003-12-18 | 알콘, 인코퍼레이티드 | 5-Hydroxy indazole derivatives for treating glaucoma |
| US7005443B1 (en) | 2000-03-17 | 2006-02-28 | Alcon, Inc. | 5-Hydroxy indazole derivatives for treating glaucoma |
| SE0004245D0 (en) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| JP4204315B2 (en) | 2000-11-20 | 2009-01-07 | ビオヴィトルム・アクチボラゲット（プブリクト） | Piperazinyl pyrazine compounds as antagonists of serotonin 5-HT2 receptors |
| CA2432122A1 (en) | 2000-12-20 | 2002-08-01 | Bristol-Myers Squibb Pharma Company | Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| DE60330864D1 (en) | 2002-06-19 | 2010-02-25 | Biovitrum Ab Publ | NEW CONNECTIONS, THEIR USE AND MANUFACTURE |
| CL2004000826A1 (en) | 2003-04-25 | 2005-03-04 | Pfizer | USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129 |
| GB0314967D0 (en) | 2003-06-26 | 2003-07-30 | Hoffmann La Roche | Piperazine derivatives |
| EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
| CA2582079A1 (en) * | 2004-09-27 | 2006-05-04 | Organix, Inc. | Indole compounds useful as serotonin selective agents |
| AP2007004144A0 (en) | 2005-03-31 | 2007-08-31 | Pfizer Prod Inc | Cyclopentapyridine and tetrahydroquinoline derivatives |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| WO2009063992A1 (en) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivative and use thereof |
| KR101062376B1 (en) | 2008-04-10 | 2011-09-06 | 한국화학연구원 | Novel indole carboxylic acid bispyridyl carboxamide derivatives, preparation method thereof and composition containing the same as an active ingredient |
| WO2011071136A1 (en) | 2009-12-11 | 2011-06-16 | アステラス製薬株式会社 | Therapeutic agent for fibromyalgia |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
| IL313857A (en) * | 2021-12-24 | 2024-08-01 | Psylo Pty Ltd | Compounds |
| WO2025000053A1 (en) * | 2023-06-28 | 2025-01-02 | Psylo Pty Ltd | Compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0494774A1 (en) * | 1991-01-11 | 1992-07-15 | MERCK SHARP & DOHME LTD. | Indazole-substituted fivemembered heteroaromatic compounds |
| JPH08165276A (en) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | 2-alkylamino-1-phenylethanol derivative |
| JP3560986B2 (en) * | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | 5-HT2C receptor agonist and aminoalkylindazole derivative |
-
1998
- 1998-09-01 GB GBGB9819020.0A patent/GB9819020D0/en not_active Ceased
-
1999
- 1999-09-01 AU AU56374/99A patent/AU5637499A/en not_active Abandoned
- 1999-09-01 WO PCT/GB1999/002883 patent/WO2000012482A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000012482A2 (en) | 2000-03-09 |
| WO2000012482A3 (en) | 2000-05-25 |
| GB9819020D0 (en) | 1998-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2093597A (en) | Chemical compounds | |
| GB9800428D0 (en) | Chemical compounds | |
| GB9812709D0 (en) | Chemical compounds | |
| GB9811159D0 (en) | Chemical compounds | |
| AU5052199A (en) | Chemical compounds | |
| GB9819382D0 (en) | Chemical compounds I | |
| AU5637499A (en) | Chemical compounds iii | |
| AU1424200A (en) | Compounds | |
| GB9812088D0 (en) | Chemical compounds | |
| AU4501699A (en) | Aminoazole compounds | |
| GB9804343D0 (en) | Chemical compounds | |
| GB9928414D0 (en) | Chemical compounds III | |
| AU6104599A (en) | Chemical compounds viii | |
| GB9804861D0 (en) | Chemical compounds | |
| AU1434500A (en) | Compounds | |
| AU1872900A (en) | Chemical compounds | |
| AU5050899A (en) | Chemical compounds | |
| GB9801812D0 (en) | Chemical compounds | |
| AU5661399A (en) | Compounds | |
| GB9802028D0 (en) | Chemical compounds | |
| AU5689400A (en) | Chemical compounds | |
| AU3715899A (en) | Di-peroxy compounds | |
| GB9801499D0 (en) | Chemical compounds iii | |
| AUPP298598A0 (en) | Neurologically-active compounds | |
| GB9826358D0 (en) | Chemical compounds I |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |